# NUTRIVENTION-4 (NCT04497961)

> A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04497961
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Memorial Sloan Kettering Cancer Center
- Conditions: Multiple Myeloma
- Interventions: Lenalidomide; Daratumumab; Questionnaires; Dietary Intervention
- Enrollment: 95
- Primary outcome: Difference in the global health status

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 2
- Bluesky threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nutrivention-4-nct04497961